SAFETY AND CLINICAL EFFICACY IN BIOSIMILAR SUBSTITUTION
Biosimilar medicinal products have become a reality in recent years. Despite an established legal pathway for biosimilars in the European Union since 2005 and increasing regulatory guidance on data requirements for their development and approval, many clinicians are still reluctant to consider biosi...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Libro |
| Publicado: |
Formifarma, LDA.,
2015-01-01T00:00:00Z.
|
| Materias: | |
| Acceso en línea: | Connect to this object online. |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Internet
Connect to this object online.3rd Floor Main Library
| Número de Clasificación: |
A1234.567 |
|---|---|
| Copia 1 | Disponible |